Luvometinib
Luvometinib is a mitogen-activated protein kinase (MEK) inhibitor with antitumor activity[1].
Product Specifications
CAS Number
2739690-43-6
UNSPSC
12352005
Target
MEK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/luvometinib.html
Purity
99.94
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1C(F)=C(C2=C(N1C)C(C3=CC(NS(=O)(C4CC4)=O)=CC=C3)=NN(C5CC5)C2=O)NC6=CC=C(C=C6F)I
Molecular Formula
C26H22F2IN5O4S
Molecular Weight
665.45
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 38, No. 2, 2024.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-61318R-BF647-01 20 µL
CaMK2 alpha Recombinant Antibody, AbBy Fluor™ 647 Conjugated
Sign In for Pricing
View Details